FI921786A7 - Farmaceutisk foerening - Google Patents

Farmaceutisk foerening Download PDF

Info

Publication number
FI921786A7
FI921786A7 FI921786A FI921786A FI921786A7 FI 921786 A7 FI921786 A7 FI 921786A7 FI 921786 A FI921786 A FI 921786A FI 921786 A FI921786 A FI 921786A FI 921786 A7 FI921786 A7 FI 921786A7
Authority
FI
Finland
Prior art keywords
pharmaceutical association
pharmaceutical
association
Prior art date
Application number
FI921786A
Other languages
English (en)
Finnish (fi)
Other versions
FI921786A0 (fi
Inventor
Gary Alan Hite
Edward David Mihelich
David Wells Snyder
Tulio Suarez
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI921786A0 publication Critical patent/FI921786A0/fi
Publication of FI921786A7 publication Critical patent/FI921786A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43—Y being a hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/46—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms
    • C07C323/47—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms to oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI921786A 1991-04-23 1992-04-22 Farmaceutisk foerening FI921786A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69020491A 1991-04-23 1991-04-23

Publications (2)

Publication Number Publication Date
FI921786A0 FI921786A0 (fi) 1992-04-22
FI921786A7 true FI921786A7 (fi) 1992-10-24

Family

ID=24771539

Family Applications (1)

Application Number Title Priority Date Filing Date
FI921786A FI921786A7 (fi) 1991-04-23 1992-04-22 Farmaceutisk foerening

Country Status (17)

Country Link
US (1) US5283361A (cs)
EP (1) EP0510948A1 (cs)
JP (1) JPH05117227A (cs)
KR (1) KR920019740A (cs)
CN (1) CN1066062A (cs)
AU (1) AU638641B2 (cs)
BR (1) BR9201452A (cs)
CA (1) CA2066508A1 (cs)
CS (1) CS119492A3 (cs)
FI (1) FI921786A7 (cs)
HU (1) HUT62557A (cs)
IE (1) IE921279A1 (cs)
IL (1) IL101625A0 (cs)
MX (1) MX9201808A (cs)
NO (1) NO921530L (cs)
TW (1) TW199141B (cs)
ZA (1) ZA922873B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05294921A (ja) * 1992-04-17 1993-11-09 Pfizer Pharmaceut Co Ltd 新規なフェニル置換シクロアルキル尿素誘導体および組成物
JP2756732B2 (ja) * 1993-12-22 1998-05-25 ファイザー製薬株式会社 リポキシゲナーゼ阻害剤としてのフェニルチオフェニルシクロアルケニルヒドロキシ尿素
US5891460A (en) * 1995-06-07 1999-04-06 University Of Southern California University Park Campus Method for reducing or preventing post-surgical adhesion formation using ketotifen and analogs thereof
JP3929140B2 (ja) 1997-10-27 2007-06-13 日本碍子株式会社 耐蝕性部材およびその製造方法
EP4008327A1 (en) 2009-04-29 2022-06-08 Amarin Pharmaceuticals Ireland Limited Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
CN102659637B (zh) * 2012-05-21 2014-05-14 上海大学 一种制备双羟基脲的新方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU602485B2 (en) * 1985-03-16 1990-10-18 Wellcome Foundation Limited, The Lipoxygenase and/or cyclooxygenase inhibitory compounds
US5185363A (en) * 1986-04-25 1993-02-09 Abbott Laboratories Urea based lipoxygenase inhibiting compounds
GB8619593D0 (en) * 1986-08-12 1986-09-24 Roussel Lab Ltd Chemical compounds
EP0279263B1 (en) * 1987-02-10 1993-08-04 Abbott Laboratories Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds
NZ232350A (en) * 1989-02-03 1992-04-28 Wellcome Found N-(1-methyl-3-((halophenoxy)phenyl)prop-2-en-1-yl)-n-hydroxyurea derivatives and pharmaceutical compositions
CA2050597A1 (en) * 1989-03-30 1990-10-01 Dee W. Brooks Urea based lipoxygenase inhibiting compounds
US5130485A (en) * 1991-04-23 1992-07-14 Eli Lilly And Company N-hydroxy-N-(3-(2-substituted phenyl)prop-2-enyl)ureas and thioureas useful as 5-lipoxygenase inhibiting agents

Also Published As

Publication number Publication date
CN1066062A (zh) 1992-11-11
JPH05117227A (ja) 1993-05-14
CA2066508A1 (en) 1992-10-24
KR920019740A (ko) 1992-11-19
CS119492A3 (en) 1992-12-16
AU638641B2 (en) 1993-07-01
NO921530D0 (no) 1992-04-21
NO921530L (no) 1992-10-26
BR9201452A (pt) 1992-12-01
TW199141B (cs) 1993-02-01
HUT62557A (en) 1993-05-28
IE921279A1 (en) 1992-11-04
US5283361A (en) 1994-02-01
FI921786A0 (fi) 1992-04-22
ZA922873B (en) 1993-10-21
IL101625A0 (en) 1992-12-30
AU1500992A (en) 1992-10-29
HU9201343D0 (en) 1992-07-28
EP0510948A1 (en) 1992-10-28
MX9201808A (es) 1994-05-31

Similar Documents

Publication Publication Date Title
FI930737A7 (fi) Asialoglykoproteiiniin sidottu lääkeaine
DK0616523T3 (da) Lægemidler
NO923127D0 (no) Farmasoeytisk kombinasjonsformulering
NO920067D0 (no) Foradditiv for droevtyggere
DK0515312T3 (da) Farmaceutisk præparat
EE03108B1 (et) Farmatseutiline kompositsioon
FI981777L (fi) Farmaseuttinen ainekoostumus
DK0585252T3 (da) Farmaceutiske formuleringer
FI921060A0 (fi) Farmaceutiska aerosolformuleringar.
NO942923L (no) Medikamenter
NO923859D0 (no) Medikament
FI930882A0 (fi) Farmaceutiska foereningar
FI934194L (fi) Kontrastmedel
MX9200622A (es) Composicion farmaceutica
NO934145D0 (no) Farmas!ytiske forbindelser
FI931251A0 (fi) Farmaceutiska foereningar
FI921786A7 (fi) Farmaceutisk foerening
FI921785A7 (fi) Farmaceutisk foerening
FI923869L (fi) Farmaceutiska aemnen
BR9206845A (pt) Composto famacêutico
SE9103213D0 (sv) Farmaceutisk komposition
SE9101348D0 (sv) Pharmaceutical composition
NO920564D0 (no) Farmasoeytiske adenosinholdige preparater

Legal Events

Date Code Title Description
FD Application lapsed